Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26Neoplasms 18Prostatic Neoplasms 11Lung Neoplasms 7Sarcoma 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Lymphoma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Signs and Symptoms 2Papillomavirus Infections 2Pain 2Multiple Myeloma 2Melanoma 2Gastrointestinal Neoplasms 2Financial Stress 2Endometrial Neoplasms 2Depression 2Coitus 2Chronic Pain 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2

Interventions

pembrolizumab 2darolutamide 2relatlimab 1olaparib 1gedatolisib 1enfortumab vedotin 1Surveys and Questionnaires 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Mitomycin 1Gemcitabine 1Fluorouracil 1Cisplatin 1CP protocol 1Blood Specimen Collection 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Male Urogenital Diseases × Surveys and Questionnaires × Clear all
NCT06659926 2025-07-08

The Radium-select Study

The Netherlands Cancer Institute

Phase NA Recruiting
60 enrolled

Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡